Literature DB >> 18360314

Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.

Donna J Helms1, Debra J Mosure, Carol A Metcalf, John M Douglas, C Kevin Malotte, Sindy M Paul, Thomas A Peterman.   

Abstract

GOAL: Trichomonas vaginalis is the most common nonviral sexually transmitted infection in the United States and may be associated with adverse birth outcomes and may also increase susceptibility to or transmissibility of human immunodeficiency virus. The purpose of this analysis is to describe the epidemiology of T. vaginalis in Sexually Transmitted Disease clinics and characterize the risk factors associated with prevalent and incident T. vaginalis within the same population.
METHODS: We analyzed data from visits occurring during February 1999-December 2001 from 3 sexually transmitted disease clinics in Newark, NJ; Long Beach, CA; and Denver, CO. Data were analyzed from 1462 women aged 15 to 39 years who were tested by culture at their initial visit for T. vaginalis, and for 1269 women with at least 1 follow-up visit. Risk factors for prevalent infections at baseline and incident infections among treated or previously uninfected women were assessed.
RESULTS: At baseline, 13.0% of the women had a prevalent infection; risk factors included the following: older age (> or =20 years), black race, having less than 12 years of education, and having a concurrent chlamydial infection. At follow-up, 4.6% of women had an incident infection; risk factors included the following: older age (35-39 years), black race, having a concurrent chlamydial infection, having had multiple sexual partners in the 3 months before incident infection, and having had T. vaginalis at the visit before their incident infection.
CONCLUSIONS: T. vaginalis incidence is high in women. Risk factors for prevalent and incident infection are similar. T. vaginalis was associated with older age in women, unlike other sexually transmitted infections.

Entities:  

Mesh:

Year:  2008        PMID: 18360314     DOI: 10.1097/OLQ.0b013e3181644b9c

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  35 in total

1.  Incidence of sexually transmitted infections among hazardously drinking women after incarceration.

Authors:  Michael D Stein; Celeste M Caviness; Bradley J Anderson
Journal:  Womens Health Issues       Date:  2011-08-10

2.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

3.  Clinical Trial Report: Duration of Metronidazole Therapy in HIV-infected Women with Trichomonas vaginalis: Is More Metronidazole Better?

Authors:  Laura H Bachmann
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

4.  A Trich-y question: should Trichomonas vaginalis infection be reportable?

Authors:  Brooke E Hoots; Thomas A Peterman; Elizabeth A Torrone; Hillard Weinstock; Elissa Meites; Gail A Bolan
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

5.  Trichomonas vaginalis: treatment questions and challenges.

Authors:  W Evan Secor
Journal:  Expert Rev Anti Infect Ther       Date:  2012-02       Impact factor: 5.091

6.  Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.

Authors:  C C Ginocchio; K Chapin; J S Smith; J Aslanzadeh; J Snook; C S Hill; C A Gaydos
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

7.  Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.

Authors:  Elissa Meites; Eloisa Llata; Jim Braxton; Jane R Schwebke; Kyle T Bernstein; Preeti Pathela; Lenore E Asbel; Roxanne P Kerani; Christie J Mettenbrink; Hillard S Weinstock
Journal:  Sex Transm Dis       Date:  2013-11       Impact factor: 2.830

8.  Quantity, not frequency, of alcohol use moderates the association between multiple sexual partners and Trichomonas vaginalis among women attending an urban STD clinic.

Authors:  Lori A J Scott-Sheldon; Theresa E Senn; Kate B Carey; Marguerite A Urban; Michael P Carey
Journal:  Sex Transm Infect       Date:  2013-04-11       Impact factor: 3.519

9.  Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment.

Authors:  Charlotte A Gaydos; Mathilda R Barnes; Nicole Quinn; Mary Jett-Goheen; Yu-Hsiang Hsieh
Journal:  Sex Transm Infect       Date:  2013-01-26       Impact factor: 3.519

10.  A service evaluation of the Gen-Probe APTIMA nucleic acid amplification test for Trichomonas vaginalis: should it change whom we screen for infection?

Authors:  Emma Hathorn; Andrea Ng; Matthew Page; James Hodson; Charlotte Gaydos; Jonathan D C Ross
Journal:  Sex Transm Infect       Date:  2014-08-28       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.